Not yet recruiting
End stage renal disease
Not yet recruitingA study of canagliflozin and 18F-canagliflozin in patients with chronic kidney disease undergoing dialysis
Registered drugNo placebo
A study of canagliflozin and 18F-canagliflozin in patients with chronic kidney disease undergoing dialysis
Registered drugNo placebo
- Disease:End stage renal disease
- Substances:Canagliflozin[18F] CANAGLIFLOZIN
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Canagliflozin
